Influence of PXR Haplotype Variants on Paclitaxel and Docetaxel Pharmacokinetics and Pharmacodynamics in Asian Cancer Patients

被引：0
|
作者：
Chowbay, Balram [1 ]
Sandanaraj, Edwin [1 ]
Lal, Suman [1 ]
Wang Zhenping [1 ]
Teck, Lim Wan [2 ]
Siang, Ang Cher [2 ]
Lee, Edmund [3 ]
Huat, Tan Eng [2 ]
机构：
[1] Natl Canc Ctr, Div Med Sci, Clin Pharmacol Lab, Singapore 117548, Singapore
[2] Natl Canc Ctr, Dept Med Oncol, Singapore, Singapore
[3] Natl Univ Singapore, Dept Pharmacol, Singapore, Singapore
来源：
DRUG METABOLISM REVIEWS | 2009年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
123
引用
收藏
页码：56 / 56
页数：1
相关论文
共 50 条
  • [21] Influence of paclitaxel (PAC) on topotecan (TPT) pharmacokinetics (PK) in advanced cancer patients
    Schuller, J
    Czejka, M
    Krexner, E
    Springer, B
    Eder, I
    Terkola, R
    Scheiber, B
    ANNALS OF ONCOLOGY, 1998, 9 : 132 - 132
  • [22] Influence of formulation on propofol pharmacokinetics and pharmacodynamics in anesthetized patients
    Calvo, R
    Telletxea, S
    Leal, N
    Aguilera, L
    Suarez, E
    De La Fuente, L
    Martin-Suarez, A
    Lukas, JC
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2004, 48 (08) : 1038 - 1048
  • [23] Genetic variants in human carbonyl reductase 3 (CBR3) and their influence on doxorubicin pharmacokinetics in Asian breast cancer patients
    Fan, L.
    Guo, J. Y.
    Wong, C. I.
    Lim, R.
    Yap, H. L.
    Khoo, Y. M.
    Iau, P.
    Goh, B. C.
    Lee, H. S.
    Lee, S. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [24] Influence of amifostine on the toxicity and pharmacokinetics of docetaxel in metastatic breast cancer patients: A pilot study
    Freyer, G
    Hennebert, P
    Awada, A
    Gil, T
    Kerger, J
    Selleslags, J
    Brassinne, C
    Piccart, M
    de Valeriola, D
    CLINICAL CANCER RESEARCH, 2002, 8 (01) : 95 - 102
  • [25] Nonlinear pharmacokinetics of paclitaxel in ovarian cancer patients
    Ye, M
    Zhu, Z
    Fu, Q
    Shen, K
    Li, DK
    ACTA PHARMACOLOGICA SINICA, 2000, 21 (07) : 596 - 599
  • [26] The pharmacokinetics and pharmacodynamics of docetaxel (DCTX) in Caucasian and African American patients with solid tumors.
    Lewis, LD
    Rosner, GL
    Miller, AA
    Egorin, MJ
    Relling, MV
    Kastrissios, H
    Bies, R
    Ratain, MJ
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 137S - 137S
  • [27] PHARMACOKINETICS, PHARMACODYNAMICS, AND ANTIMICROBIALS IN CANCER PATIENTS WITH KIDNEY DYSFUNCTION
    Keller, E.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : E115 - E115
  • [28] Pharmacokinetics and pharmacodynamics of mood altering drugs in patients with cancer
    Lovejoy, NC
    Matteis, M
    CANCER NURSING, 1996, 19 (06) : 407 - 418
  • [29] Pharmacodynamics, pharmacokinetics and safety of ticagrelor in Asian patients with stable coronary artery disease
    Hiasa Y.
    Teng R.
    Emanuelsson H.
    Cardiovascular Intervention and Therapeutics, 2014, 29 (4) : 324 - 333
  • [30] CYP2C8 haplotype structures and their influence on pharmacokinetics of paclitaxel in a Japanese population
    Saito, Yoshiro
    Katori, Noriko
    Soyama, Akiko
    Nakajima, Yukiko
    Yoshitani, Takashi
    Kim, Su-Ryang
    Fukushima-Uesaka, Hiromi
    Kurose, Kouichi
    Kaniwa, Nahoko
    Ozawa, Shogo
    Kamatani, Naoyuki
    Komamura, Kazuo
    Kamakura, Shiro
    Kitakaze, Masafumi
    Tomoike, Hitonobu
    Sugai, Kenji
    Minami, Narihiro
    Kimura, Hideo
    Goto, Yu-ichi
    Minami, Hironobu
    Yoshida, Teruhiko
    Kunitoh, Hideo
    Ohe, Yuichiro
    Yamamoto, Noboru
    Tamura, Tomohide
    Saijo, Nagahiro
    Sawada, Jun-Ichi
    PHARMACOGENETICS AND GENOMICS, 2007, 17 (07): : 461 - 471
12345